Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$17.41 USD
+0.28 (1.63%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $17.40 -0.01 (-0.06%) 6:14 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | 15.38% |
ABR | 1.17 |
Earnings ESP
|
0.28% |
---|---|
Current Year | -1.59 |
Next Year | -1.98 |
EPS (TTM) | -1.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.37 | -1.59 | -1.98 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.37 | -0.43 | -1.76 | -2.79 |
High Estimate | -0.31 | -0.32 | -1.32 | -1.41 |
Low Estimate | -0.41 | -0.43 | -2.20 | -2.79 |
Year ago EPS | -0.34 | -0.41 | -1.57 | -1.59 |
Year over Year Growth Est. | -5.88% | 9.76% | -1.27% | -24.28% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 3 | 2 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.37 | -1.59 | -1.98 |
7 Days Ago | -0.36 | -0.37 | -1.59 | -1.98 |
30 Days Ago | -0.39 | -0.41 | -1.76 | -1.91 |
60 Days Ago | -0.39 | -0.41 | -1.76 | -1.91 |
90 Days Ago | -0.38 | -0.41 | -1.71 | -1.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.38 | -1.62 | -2.06 |
Zacks Consensus Estimate | -0.36 | -0.37 | -1.59 | -1.98 |
Earnings ESP | 0.28% | -2.70% | -1.32% | -3.91% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.47 | -0.41 | -0.34 | NA |
Estimate | -0.39 | -0.44 | -0.40 | -0.41 | NA |
Difference | 0.06 | -0.03 | -0.01 | 0.07 | 0.02 |
Surprise | 15.38% | -6.82% | -2.50% | 17.07% | 5.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more